GMS Ventures & Investments - 27 May 2025 SCHEDULE 13D/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing Manager: GMS Ventures & Investments
Reporting Manager: GMS VENTURES & INVESTMENTS
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 57,735,445 shares
Disclosed Ownership: 29,040,929 shares
Ownership: 50%
Form type: SCHEDULE 13D/A
Filing time: 28 May 2025, 17:24:49 UTC
Date of event: 27 May 2025
Previous filing: 12 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GMS VENTURES & INVESTMENTS	50%	29,040,929	0	29,040,929	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001804598
SUKHTIAN GHIATH M.	50%	29,040,929	0	29,040,929	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001717441